Bioelectronics Corp (BIEL)

[Det_Robert_Thorne]

More to do with $591K of current notes

I would say they're ramping up production for the major rollout and to meet overseas increased demand for NHS reimbursement and b. braun post op kit.

The increase in OS probably has a lot more to do with converting part of the $591.2K of Notes Payable (as of June 30) into shares for sale into the market.

And of course, since BIEL only had about $34K in cash at the end of 2Q/18, the company likely issued more convertible debt during the third quarter for the ramp up and rollout. We'll find out about that new debt in about a month, when BIEL files its 3Q/18 disclosures.